These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4509041)

  • 41. Effect of neuraminidase on lymphoid cells. Differences in structure of B and T cells and thymocytes of the mouse shown by cell electrophoresis and sialic acid determination.
    Wiig JN
    Scand J Immunol; 1974; 3(3):357-63. PubMed ID: 4604390
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of antiplasma cell sera on the primary immune response.
    Harris NS; Jagarlamoody SM; McKhann CF; Najarian JS
    J Immunol; 1972 Apr; 108(4):958-64. PubMed ID: 4554015
    [No Abstract]   [Full Text] [Related]  

  • 43. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 44. Agglutinating and cytotoxic properties of anti-leukemic sera specific against human leukemic cells, produced in rabbits.
    Sahasrabudhe MB; Prema S; Madyastha KR; Gollerkeri MP
    Indian J Cancer; 1972 Sep; 9(3):189-98. PubMed ID: 4511450
    [No Abstract]   [Full Text] [Related]  

  • 45. [Extended survival of allographs in mice following the injection of transplantation antigens pre-treated with normal serum. II. Mode of action (author's transl)].
    Elie R; Lamoureux G
    Ann Immunol (Paris); 1974 Jun; 125 C(4):645-53. PubMed ID: 4615620
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of blocking antibodies in immunological enhancement.
    Takasugi M; Klein E
    Immunology; 1971 Oct; 21(4):675-84. PubMed ID: 5121758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 48. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
    [No Abstract]   [Full Text] [Related]  

  • 49. Removal of neuraminic acid from H-2 alloantigens without effect of antigenic reactivity.
    Shimada A; Nathenson SG
    J Immunol; 1971 Oct; 107(4):1197-9. PubMed ID: 5093779
    [No Abstract]   [Full Text] [Related]  

  • 50. Cooperation of normal and malignant lymphoid cells in the immune response against sheep erythrocytes.
    Boranić M; Hrsak I; Marotti T; Mazuran R; Silobrcić V
    Biomedicine; 1974 Jan; 21(1):9-12. PubMed ID: 4858487
    [No Abstract]   [Full Text] [Related]  

  • 51. Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):600-4. PubMed ID: 5118473
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence for non-exposed H-2 antigens in immunoresistant murine tumour.
    Friberg S; Lilliehöök B
    Nat New Biol; 1973 Jan; 241(108):112-4. PubMed ID: 4512450
    [No Abstract]   [Full Text] [Related]  

  • 53. Regeneration of the surface glycoproteins of a transplantable mouse tumor cell after treatment with neuraminidase.
    Hughes RC; Sanford B; Jeanloz RW
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):942-5. PubMed ID: 4502944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytotoxic effect of normal rabbit serum on human lymphoid cells.
    Flye MW; Schlesinger M; Amos DB
    Transplantation; 1973 Aug; 16(2):117-21. PubMed ID: 4542410
    [No Abstract]   [Full Text] [Related]  

  • 55. Synergistic cytotoxic effect of macrophages and normal mouse serum on neuraminidase-treated murine leukaemia cells.
    Sethi KK; Brandis H
    Eur J Cancer (1965); 1973; 9(11-12):809-19. PubMed ID: 4613554
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase.
    Simmons RL; Rios A; Ray PK
    Nat New Biol; 1971 Jun; 231(23):179-81. PubMed ID: 4931977
    [No Abstract]   [Full Text] [Related]  

  • 57. Sialic acid on leukemia cells: relation to morphology and tumor immunity.
    Reed RC; Gutterman JU; Mavlight GM; Hersh EM
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):790-3. PubMed ID: 4522465
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells.
    Ray PK; Simmons RL
    Clin Exp Immunol; 1972 Jan; 10(1):139-50. PubMed ID: 4335984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on the nature of receptors involved in attachment of tissue culture cells to mycoplasmas.
    Manchee RJ; Taylor-Robinson D
    Br J Exp Pathol; 1969 Feb; 50(1):66-75. PubMed ID: 5773147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolism of Campylobacter spp. (Vibrio spp.) in connexion with pathogenicity and the use of neuraminidase to suppress pregnancy.
    Morris JA; Park RW
    Nature; 1971 Jul; 232(5306):132-3. PubMed ID: 4933250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.